Open the mobile version, with barcode scanning
Class II Ongoing

Adenosine-Mono-Phosphate Injection, 200 mg/ml, compounded by Olympia Pharmacy, Orlando, FL

Why: Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

Company
Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Orlando, FL, United States
Reported
Jul 17, 2013
Recall started
May 29, 2013
Where sold
Nationwide and PR
Amount
1
Full product description
Adenosine-Mono-Phosphate Injection, 200 mg/ml, compounded by Olympia Pharmacy, Orlando, FL
Lots / codes affected
A5631 exp 12/31/13

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.